Children hospitalized with severe pneumonia who switched from intravenous antibiotics to pills once they started improving went home a day earlier than children kept on IV treatment, and they were no more likely to be readmitted or to die within 28 days.
The finding comes from the PediCAP trial, published in The Lancet and summarized by CIDRAP. Investigators randomly assigned 1,101 children aged two months to six years with severe community-acquired pneumonia at 13 hospitals across sub-Saharan Africa.
